Upregulation of human telomerase reverse transcriptase (hTERT) transcription accounts for the immortalization of greater than 85% of all human tumor cells. However, the mechanism whereby hTERT expression is activated remains unresolved. Specifically, recent data challenging the role of Myc/Max in E-box-dependent activation of hTERT expression suggests that other E-box-binding proteins regulate hTERT transcription. Indeed, we now demonstrate that two such proteins, upstream stimulatory factor (USF) 1 and 2, readily associate with two E-boxes in the hTERT promoter in vitro and in vivo primarily as heterodimers, whereas Myc/Max does not. The avid binding of USF1/2 heterodimers to these E-boxes occurs in both hTERT-positive and -negative cells. In contrast, USF1/2 activates the hTERT promoter exclusively in hTERT-positive cells in a manner that is enhanced by the coactivator p300 and attenuated upon inhibiting p38-MAP kinase, a known modulator of USF activity. Collectively, our data indicate that USF binding to the hTERT promoter may be transcriptionally neutral, or even repressive, in nonimmortalized hTERT-negative somatic cells, but stimulatory in hTERT-positive cells where USF1/2 contributes to the acquisition and maintenance of immortality.
As telomere length is a major determinant of cellular longevity, immortal cells often employ telomerase, a ribonucleoprotein that elongates telomeres, to maintain telomere length (Blackburn, 2001) . Indeed, most somatic cells lack telomerase activity, whereas greater than 85% of all human tumor cells possess telomerase activity (Hiyama and Hiyama, 2002) . This differential display of telomerase activity is largely attributed to the ability of tumor cells to upregulate expression of the catalytic subunit of telomerase, human telomerase reverse transcriptase (hTERT) (Aisner et al., 2002) . However, little is presently known about how hTERT is transcriptionally upregulated in tumor cells. Even the effect of the E-box-binding proto-oncoprotein Myc, heavily implicated in hTERT transcription (Poole et al., 2001; Ducrest et al., 2002) , remains poorly understood as recent reports illustrated that the effect of Myc on hTERT expression is cell type specific (Drissi et al., 2001) and additional E-box-binding proteins may regulate hTERT transcription (Ducrest et al., 2001; Horikawa et al., 2002) .
Upstream stimulatory factor (USF), like Myc, is a bHLH-zip protein that binds to gene promoters containing a consensus sequence referred to as an E-box (5 0 -CACGTG-3 0 ). Two variants of USF have been described, USF1 and USF2, that are structurally and functionally related proteins derived from distinct genes (Gregor et al., 1990; Sirito et al., 1992) . Both the proteins are ubiquitously expressed and associate with E-boxes as homo-and heterodimers (Sirito et al., 1994; Viollet et al., 1996) . Although USF1 and USF2 were initially postulated to be involved solely in the regulation of housekeeping genes, USF proteins differentially regulate the transcription of numerous genes in response to various signals (Muhlethaler-Mottet et al., 1998; Galibert et al., 2001; Heckert, 2001; Kumari and Usdin, 2001) . Indeed, USF has recently been implicated in the differential expression of hTERT in quiescent and activated lymphocytes and accordingly binds to the hTERT promoter in vitro (Horikawa et al., 2002; Yago et al., 2002) . However, as the impact of USF on hTERT expression in tumor cells is completely unresolved, we assessed the ability of USF to bind and transcriptionally activate the hTERT promoter in tumor cells relative to somatic cells.
To determine the importance of USF in hTERT expression, we studied whether USF activates the hTERT promoter in immortalized 293T cells. We found that USF1 activated a luciferase reporter gene under the control of the full-length hTERT promoter (À3337/ þ 438), but had no effect on the parental luciferase vector, pGL2-Basic (Figure 1a ). Deletion of upstream hTERT promoter regions revealed that USF activated the hTERT promoter via elements lying between nucleotides À233 and þ 438 of the hTERT gene. Furthermore, USF2, as did USF1, activated this region of the hTERT promoter, and joint expression of USF1 and USF2 greatly enhanced hTERT promoter activity relative to expression of each protein alone (Figure 1b) . Therefore, we surmised that USF regulates the hTERT promoter primarily as a heterodimer by binding to the upstream (À165 to À160) and/or downstream ( þ 44 to þ 49) E-box present in the À233 to þ 438 hTERT core promoter (Poole et al., 2001; Ducrest et al., 2002) . Consistently, mutation of each of these E-boxes significantly abrogated promoter responsiveness to USF and mutation of both sites further impaired the ability of USF to activate the hTERT promoter ( Figure 1c) .
To demonstrate that USF binds to the aforementioned E-boxes of the hTERT core promoter, we generated double-stranded oligonucleotides corresponding to both E-boxes and employed them in electrophoretic mobility shift assays with lysates derived from hTERT-positive, immortalized OVCAR3 ovarian cancer cells. As shown in Figure 2a , several proteins present in OVCAR3 cells associated with hTERT oligonucleotides encompassing both E-boxes. However, only one of the upstream E-box : protein and one of the downstream E-box : protein complexes were supershifted by antibodies to USF1 and USF2, thereby indicating that these complexes contained USF. Additionally, as both anti-USF1 and anti-USF2 antibodies supershifted the majority of the upstream and downstream USF : DNA complexes, our data suggested that USF associates with the hTERT promoter primarily as a heterodimer. The binding of USF1/2 to the upstream and downstream Eboxes was specific as it was abolished by the respective nonradiolabeled oligonucleotides, whereas mutant oligonucleotides, in which the 5 0 -CACGTG-3 0 E-box has been mutated to 5 0 -AAAGTG-3 0 , had no effect ( Figure 2a ). Protein binding of the E-boxes was unchanged by the addition of anti-Myc and anti-Max antibodies (Figure 2a ), likely due to the fact that USF1/ 2 precludes binding of Myc/Max to the hTERT promoter. Thus, even overexpression of Myc and Max in OVCAR3 cells failed to reduce USF1/2 binding of the E-boxes and Myc/Max binding of the hTERT E-boxes remained undetectable (data not shown). These results indicate that USF1/2 binds more avidly to the hTERT E-boxes than does Myc/Max, a corollary of which is that Myc/Max binding of the hTERT promoter does not significantly contribute to hTERT expression in hTERT-positive OVCAR3 cells.
To determine if the ability of USF1/2 to bind to the hTERT E-boxes correlates with hTERT expression and telomerase activity, we incubated the aforementioned radiolabeled probes with lysates derived from five additional immortalized, hTERT-positive cell lines (SKBR3, MDA-MB-231, MCF7, 293T, SKOV3) and three nonimmortalized, hTERT-negative cell lines (Wi38, HFF, BJ). The hTERT and telomerase status of each cell line was confirmed by RT-PCR and telomeric repeat amplification protocol (TRAP) assay, respectively (Figure 2c and d) . As illustrated in Figure 2b , USF1/2 binding of the hTERT E-boxes was detected in every cell line tested, thereby indicating that differential binding of USF to the hTERT promoter does not account for differences observed in hTERT expression between immortalized and nonimmortalized cells.
To further explore the interaction of USF1/2 with the hTERT promoter, we assessed the ability of USF1/2 to bind to the hTERT E-boxes in vivo via chromatin immunoprecipitations. Utilization of antibodies against USF1 and USF2 precipitated both the upstream and Figure 1 USF stimulates hTERT promoter activity. (a) hTERT promoter (1 mg) constructs or the parental pGL2-Basic vector were cotransfected, where indicated, with 1 mg of a flag-tagged USF1 expression plasmid into 293T cells using the calcium phosphate coprecipitation method. At 36 h post-transfection, luciferase activity was determined as described (Bredemeier-Ernst et al., 1997) . (b) 293T cells transiently transfected with the luciferase reporter corresponding to the core hTERT promoter (À233/ þ 438) and USF1, USF2, or both expression plasmids as designated were analysed for luciferase activity. (c) Analogous, the effect of mutating from CACGTG to AAAGTG the downstream E-box ( þ 44 to þ 49, DE d ), the upstream E-box (À165 to À160, DE u ), or both E-boxes (DE u,d ) in the hTERT core promoter (À233 to þ 438) , or a 10-fold excess of the respective nonlabeled wild-type or mutated (E-box mutated from CACGTG to AAAGTG) oligonucleotide was added. Cell lysates were obtained and electrophoretic mobility shift assays performed as previously described (Pearson et al., 1999; Bosc et al., 2001) . (b) Analogous with cell lysates from other cell lines. (c) Expression of hTERT and, as a control, GAPDH, detected on a 1% agarose gel subsequent to RT-PCR. Cytoplasmic RNA was isolated from cells as described (Bosc et al., 2001) . Thereafter, 1 mg of RNA was used for RT-PCR analysis employing the Access RT-PCR system (Promega). The temperature program and primers utilized were as described (Dhaene et al., 2000) . (d) Corresponding TRAP assay performed with the TRAPeze telomerase detection kit (Intergen). The internal control band for PCR amplification is marked by an arrow Figure 3 In vivo binding of USF to the upstream and downstream hTERT E-boxes. Chromatin immunoprecipitation assays were performed in nine different cell lines according to a published protocol (Kuo and Allis, 1999) . After immunoprecipitations with antibodies to USF1, USF2 or an irrelevant control HA epitope, the recovered DNA was analysed by PCR with primers amplifying regions encompassing the upstream E-box (À233 to À11) or downstream E-box (À11 to þ 224), or a region of the hTERT promoter that does not possess an E-box (À2899 to À2600, negative and input controls). The PCR products were stained with ethidium bromide after electrophoresis on a 1% agarose gel downstream E-box to a much larger extent than a control anti-HA antibody in all of the immortalized and nonimmortalized cell lines (Figure 3) . In contrast, anti-USF antibodies failed to precipitate an hTERT promoter fragment containing no E-box (see negative control) and an input control revealed that comparable amounts of DNA were present in the chromatin immunoprecipitations. Thus, USF1 and USF2 appear to bind to both the upstream and downstream E-boxes of the hTERT promoter in vitro and in vivo, regardless of cellular immortalization status.
As DNA binding does not necessarily equate with transcriptional activity, we considered the possibility that differential USF1/2 transcriptional activity may account for differential hTERT expression in immortalized versus nonimmortalized cells. To test this hypothesis, we utilized the hTERT (À233 to þ 438) luciferase reporter encompassing both E-boxes in transient transfections of four hTERT-positive and two hTERTnegative cell lines selected based on their amenability to transfection. As shown in Figure 4a , overexpression of USF1 resulted in activation of the hTERT promoter in all the four hTERT-positive cell lines at levels greater than or comparable to Myc/Max. On the contrary, cotransfection of the hTERT luciferase plasmid with USF1 did not result in a detectable level of luciferase activity in nonimmortalized BJ and Wi38 cells (data not shown). This lack of luciferase activity was not the result of poor transfection efficiency as a cotransfected bgalactosidase expression plasmid resulted in a robust, measurable b-galactosidase enzymatic activity (data not shown). Therefore, it appears that USF1/2, although bound to hTERT E-boxes in immortalized and nonimmortalized cells, is only transcriptionally active at the hTERT promoter in immortalized cells.
Recently, it has been shown that phosphorylation of USF by p38-MAP kinases enhances its transcriptional activity (Galibert et al., 2001) , suggesting that p38-MAP kinase may account for the observation that USF1/2 activates the hTERT promoter exclusively in tumor cells. Indeed, inhibition of p38-MAP kinases by the compound SB202190 (Lee et al., 1994) significantly attenuated USF1/2 activation of the hTERT promoter in hTERT-positive 293T cells (Figure 4b) . However, as overexpression of p38-MAP kinase and USF1/2 did not activate the hTERT promoter in hTERT-negative BJ cells (data not shown), p38-MAP kinase phosphorylation of USF, although stimulatory in tumor cells, is not sufficient to induce hTERT transcription in hTERTnegative somatic cells.
We also explored the role of p300, a coactivator of USF (Breen and Jordan, 1999) and histone acetyltransferase (Goodman and Smolik, 2000; Janknecht, 2002) , in hTERT activation. p300 enhanced the ability of USF1 to activate the hTERT promoter Btwofold in hTERT-positive 293T cells (Figure 4c) . Further, sequestration of endogenous p300 via overexpression of the adenoviral E1A protein significantly reduced hTERT promoter activity in the presence and absence of exogenous USF1, whereas an E1A mutant deficient in p300 binding, E1A-D2-36 (Liu et al., 2000) , did not. Accordingly, overexpression of p300 largely restored hTERT activation by USF in the presence of exogenous E1A. These results suggest that USF recruits p300 to the hTERT promoter, where it facilitates transcription by acetylating histones. Consistent with this notion, sodium butyrate, an inhibitor of endogenous histone (1 mg), USF2 (1 mg), p300 (5 mg), E1A (300 ng), and E1A-D2-36 (300 ng). (d) OVCAR3 cells, which were transiently transfected with the hTERT (À233/ þ 438) luciferase reporter or the parental pGL2-Basic vector and/or USF1 and USF2, were treated with 10 mm sodium butyrate 12 and 24 h prior to cell lysis and subsequent measurement of luciferase activity Regulation of telomerase reverse transcriptase gene activity BS Goueli and R Janknecht deacetylases (Horiuchi et al., 1981) , enhanced USF activation of the hTERT promoter in hTERT-positive OVCAR3 cells (Figure 4d ). However, as we were unable to induce hTERT promoter activity in hTERTnegative BJ cells via the overexpression of p300 and USF or the use of sodium butyrate (data not shown), the interaction of p300 with USF does not appear to be sufficient to induce hTERT expression in hTERTnegative cells.
Activation of telomerase is considered a prerequisite of tumorigenesis. However, little is understood as to how this is accomplished in tumor cells. To this end, we now provide evidence demonstrating that USF plays an important role in E-box-dependent hTERT transcription. USF avidly associated with two E-boxes of the hTERT promoter in vitro and in vivo in all cell lines studied, but only activated the hTERT promoter in hTERT-positive cells. Thus, USF may account for Ebox-mediated upregulation of hTERT occurring independently of Myc/Max in tumor cells (Horikawa et al., 2002) . Indeed, Myc/Max had no effect on USF occupancy of hTERT E-boxes in OVCAR3 and 293T cells in vitro as Myc/Max binding of the hTERT promoter in these cells was undetectable even when Myc/Max was overexpressed (Figure 2a and data not shown). Therefore, it is conceivable that USF proteins function as basal repressors of hTERT expression in nonimmortalized somatic cells by sequestering E-boxes to preclude significant binding of Myc/Max to the hTERT promoter.
The mechanism that accounts for the differential ability of USF to activate the hTERT promoter in hTERT-positive relative to hTERT-negative cells remains unknown. However, as recent reports have demonstrated that SP1 (Kyo et al., 2000; Won et al., 2002b) and E2F (Won et al., 2002a ) may function as both activators and repressors of hTERT expression depending on the cellular milieu, stimulatory signals that facilitate hTERT induction and the development of tumor cells may do so by enhancing USF transcriptional activity at the hTERT promoter. Indeed, inhibition of p38-MAP kinases suppresses USF activation of the hTERT promoter, and histone acetylation mediated by the USF interaction partner p300 appears to enhance USF activation of the hTERT promoter in hTERTpositive, immortal cells. Therefore, the possibility that proliferative signals that result in increased p38-MAP kinase and/or p300 acetyltransferase activity facilitate the transformation of normal cells into tumor cells by upregulating hTERT expression via USF merits further attention. Alternatively, as USF transcriptional activity has been shown to be positively modulated by other transcription factors (Muhlethaler-Mottet et al., 1998; Dillner and Sanders, 2002) , the possibility that upregulation of such proteins in tumor cells may account for the differential transcriptional activity of USF in immortalized cells versus nonimmortalized cells must be considered. Nonetheless, since we found that USF is avidly bound to the hTERT promoter in vitro and in vivo in every cell line tested and activates the hTERT promoter solely in immortalized cells, our study clearly implicates USF in hTERT expression and provides a foundation for further understanding of E-box-mediated hTERT upregulation in tumor cells.
